Clinical Trials · NCT00235937
Study on Pre-menopausal Patients With Advanced ER and PR + BC Treated With Arimidex Plus Zoladex
- Phase
- Phase 2
- Recruitment status
- Completed
- Sponsor
- AstraZeneca
- Enrollment
- 45
- Start date
- Dec 2001
- Locations
- 7 sites, France
- Primary endpoint
- Determine the feasibility and efficacy of the combination of these 2 drugs in these patients